Cite
HARVARD Citation
Bonacci, M. et al. (2018). Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone. Alimentary pharmacology & therapeutics. 47 (10), pp. 1397-1408. [Online].